In Vitro Diagnostics: Technologies and Global Market report

1. In Vitro Diagnostics: Technologies Industry [2015]

2. Summary The global market for in vitro diagnostics (IVD) products was totaled at $57.3 billion in 2014. It is expected to grow from $60.3 billion in 2015 to $81.1 billion by 2020 at a compound annual growth rate (CAGR) of 6.1% from 2015 to 2020. This report provides: -An overview of the global markets and related technologies for in vitro diagnostics -Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020

3. -Detailed coverage of application areas, end users, and factors influencing and inhibiting demand for IVD Information about IVD products including reagents, instruments, and data management softwares and services -A look at how the rise in the number of diseases like respiratory infections, hospital acquired infections (HAI), and sexually transmitted diseases are creating a constant need for infectious disease testing both in hospitals and laboratories -Segmentation into immunochemistry, clinical chemistry, SMBG, POC, MDx, hematology, microbiology, hemostasis and tissue diagnostics -Application analysis: Diabetes, infectious, oncology, cardiology, neurology and others. -Profiles of major players in the industry

4. STUDY GOALS AND OBJECTIVES This report offers a comprehensive analysis of the global in-vitro diagnostic market, along with an in-depth study of the various IVD segments (clinical chemistry, immunoassays, point-of-care diagnostics, molecular diagnostics, hematology, microbiology and tissue diagnostics); products (instruments, reagents and accessory products); end-user groups (central labs, critical care, OTC/self-testing and academia); and the regional markets of North America, Europe, Asia and LAAM (Latin America/Africa/Middle East). This report provides a complete review and analysis of the current trends in the IVD markets, along with industry growth drivers and restraints. Revenues are broken down by regions, segments, products and end users, and sales figures have been estimated for the five-year period from 2015 through 2020 in constant U.S. dollars.

5. REASONS FOR DOING THIS STUDY In vitro diagnostic tests performed on biological samples, such as blood, urine, saliva, spinal fluid and DNA, are a key component of health care delivery. The information provided by IVD tests enable medical care providers to manage several diseases through timely prevention, diagnosis and decision making, and by administering patient-specific treatment modalities. Due to recent rapid technological advances and automation, the range and complexity of diagnostic tests have overwhelmingly increased. This has made lab tests much easier to use and less error prone, with more precise and timelier results, thus transforming medical practice. These developments have in turn enabled personalized treatment through the emergence of point-of-care (POC) tests and home-based testing in the form of blood glucose meters for diabetics, pregnancy tests and cholesterol tests.

6. Today, more than 4,000 different diagnostic tests have become available, and as more IVD tests become compatible with POC environments, health care providers should take advantage of the benefits of these evolving IVDs for effective treatment of life-threatening illnesses through optimization of healthcare delivery. IVDs have already tremendously impacted cancer diagnosis and treatment globally by gaining deeper insights into genetic pathways of the disease enabled by human genome sequencing. As a result, identifying faulty genes, personalized risk predictions and tailored therapies have now become possible. Big challenges need to be addressed, however, despite IVDs being at the top of global market attractiveness index. Due to these factors, the IVD companies need to look at each country’s market landscape and IVD requirements, and then tailor their entries, launch and marketing strategies to gain a strong foot hold.

7. CONTRIBUTION OF THE STUDY AND FOR WHOM The intended audience includes all the stakeholders of the IVD market: diagnostic test manufacturing companies, disposable vendors, reagent suppliers, start-ups, technology and business incubators, venture capital firms, hospitals, diagnostic labs, physician offices and groups, university research groups and other involved participants. With its broad scope and in-depth analyses, this study is a valuable resource to anyone involved with or interested in the development and promotion of IVD technologies. Since this study provides business and technical information of a timely nature, industry analysts and investors. The projections, forecasts and trend analyses found in this report provide readers with the necessary data and information for careful decision-making and products that will best meet the needs of the IVD segment.

8. SCOPE OF REPORT The scope of this study is global. The report analyzes each market and its applications, regulatory environment, technologies involved, market projections and market shares. The emerging markets discussed include countries such as India, China, Korea, Taiwan, Africa, Australia, Brazil and Russia, among others. The report also examines the IVD market drivers as well as restraints and challenges affecting its growth. Further, the report also highlights the emerging products and technologies and associated start-ups that are likely to accelerate the growth of the IVD industry through their best practices in the research and development of IVDs. Excluded from this study are diagnostic testing such as imaging, veterinary diagnostics and their associated products.

9. This study will provide information on these areas: -Structure and current market size of the IVD market as outlined with forecasts through 2020. -Impact of chronic diseases, growing and aging populations. -Current technology and product suppliers and key innovations. -A look at the IVD industry and trends affecting the market. -Markets by each segment (immunochemistry, molecular diagnostics, POC tests, clinical microbiology, hematology and tissue diagnostics) provide a global overview showing market data for the U.S., Europe, Asia and LAAM regions. -Emerging opportunities and potential investment opportunity areas for IVD. -Technology patent trends relating to IVD. -Profiles for more than 20 companies in the industry with significant contributions and market shares.

10. METHODOLOGY Information for this report was derived from a variety of primary and secondary research sources, including industry analysts, annual reports and Securities and Exchange Commission (SEC) reports, the United Network for Organ Sharing (UNOS), the Organ Procurement and Transplantation Network (OPTN), the Scientific Registry of Transplant Recipients (SRTR), the Center for Medicare and Medicaid Services (CMS), the National Institutes of Health (NIH), the Centers for Disease Control (CDC), other government agencies and journal articles. Secondary sources include literature searches, product literature and press releases. Projections were based on estimates and information based on historical revenue trends in subsegments, validations through primary research, mergers and acquisitions, and market trends.

11. Table of Contents 1: INTRODUCTION 2: SUMMARY 3: MARKET LANDSCAPE 4: GLOBAL IVD MARKET BY SUBCATEGORIES 5: GLOBAL IMMUNOCHEMISTRY MARKET 6: GLOBAL POC TESTING MARKET 7: GLOBAL HEMATOLOGY MARKET 8: GLOBAL MOLECULAR DIAGNOSTICS MARKET 9: GLOBAL CLINICAL MICROBIOLOGY MARKET 10: GLOBAL TISSUE DIAGNOSTICS MARKET

12. To view the full Executive Summary and Table of Contents, please visit: In Vitro Diagnostics: Technologies Industry [2015] Contact Us:- Phone : +91-22-27810772/73 Email id : info@bharatbook.com Website : www.bharatbook.com Our Blog : https://www.bharatbook.com/blog/